Andres Henao, MD PhD FIDSA
@andhen25.bsky.social
A US board-certified specialist in Infectious Diseases, with a focus on fungal and tropical infections | Universidad del Valle alumnus | Associate Professor at CU Anschutz | Editor-in-Chief TAID | Associate Editor PLOSGPH | Global Health
Reposted by Andres Henao, MD PhD FIDSA
A global health journal with an all-female executive leadership team! ✨
@plosglobalpublichealth.org continues to push the boundaries with today's announcement of Prof. Manuela De Allegri joining @ckyobutungi.bsky.social as a co-editor-in-chief & @juliarobinson.bsky.social as Exec Editor
@plosglobalpublichealth.org continues to push the boundaries with today's announcement of Prof. Manuela De Allegri joining @ckyobutungi.bsky.social as a co-editor-in-chief & @juliarobinson.bsky.social as Exec Editor
November 10, 2025 at 10:32 PM
A global health journal with an all-female executive leadership team! ✨
@plosglobalpublichealth.org continues to push the boundaries with today's announcement of Prof. Manuela De Allegri joining @ckyobutungi.bsky.social as a co-editor-in-chief & @juliarobinson.bsky.social as Exec Editor
@plosglobalpublichealth.org continues to push the boundaries with today's announcement of Prof. Manuela De Allegri joining @ckyobutungi.bsky.social as a co-editor-in-chief & @juliarobinson.bsky.social as Exec Editor
Love to share our fruitful collaboration with our Peruvian scientists in the Amazon #GlobalHealth @cudivofid.bsky.social @cudeptofmedicine.bsky.social @annalsofim.bsky.social
www.acpjournals.org/doi/10.7326/...
www.acpjournals.org/doi/10.7326/...
Polymerase Chain Reaction–Confirmed Oropouche Virus Disease in Loreto, Perú: A Case Series From December 2023 Through September 2024 | Annals of Internal Medicine
www.acpjournals.org
November 11, 2025 at 1:50 AM
Love to share our fruitful collaboration with our Peruvian scientists in the Amazon #GlobalHealth @cudivofid.bsky.social @cudeptofmedicine.bsky.social @annalsofim.bsky.social
www.acpjournals.org/doi/10.7326/...
www.acpjournals.org/doi/10.7326/...
Reposted by Andres Henao, MD PhD FIDSA
🆕🔥State-of-the-Art Review with 🌟s @trubianojason.bsky.social : Antibiotic Allergy—A Multidisciplinary Approach to Delabeling #idsky
url: academic.oup.com/cid/article/...
url: academic.oup.com/cid/article/...
November 6, 2025 at 8:09 PM
🆕🔥State-of-the-Art Review with 🌟s @trubianojason.bsky.social : Antibiotic Allergy—A Multidisciplinary Approach to Delabeling #idsky
url: academic.oup.com/cid/article/...
url: academic.oup.com/cid/article/...
Reposted by Andres Henao, MD PhD FIDSA
pmc.ncbi.nlm.nih.gov/articles/PMC... cool study done by @andhen25.bsky.social and collaborators assessing the use of voriconazole vs isavuconazole for invasive aspergillosis in a population outside of a controlled environment (i.e. RCT).
Voriconazole versus isavuconazole for invasive aspergillosis: a retrospective analysis in a medically insured U.S. population (2017–2020)
While isavuconazole (ISA) has demonstrated non-inferiority to voriconazole (VCZ) for invasive aspergillosis (IA) in clinical trials, real-world comparisons are limited. To compare treatment completion, adverse events, hospitalizations, and ...
pmc.ncbi.nlm.nih.gov
October 30, 2025 at 8:59 PM
pmc.ncbi.nlm.nih.gov/articles/PMC... cool study done by @andhen25.bsky.social and collaborators assessing the use of voriconazole vs isavuconazole for invasive aspergillosis in a population outside of a controlled environment (i.e. RCT).
Reposted by Andres Henao, MD PhD FIDSA
Meta-analysis (7 studies, n=1685): Cefazolin vs. ASPs for MSSA endocarditis — similar efficacy, lower 30-day mortality (OR 0.49, 95% CI 0.29–0.83), and fewer adverse events. Supports cefazolin as a viable alternative
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
Comparative effectiveness of cefazolin versus antistaphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a systematic review of observational studies - Lau...
Background: Methicillin-susceptible Staphylococcus aureus (MSSA) is a leading cause of infective endocarditis (IE), associated with high morbidity and mortality...
journals.sagepub.com
October 28, 2025 at 1:08 PM
Meta-analysis (7 studies, n=1685): Cefazolin vs. ASPs for MSSA endocarditis — similar efficacy, lower 30-day mortality (OR 0.49, 95% CI 0.29–0.83), and fewer adverse events. Supports cefazolin as a viable alternative
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
Reposted by Andres Henao, MD PhD FIDSA
📈 Retrospective time-series study (2014–2019, Mysuru, India):
Rising temperature, humidity, and monsoon rainfall were linked to increased Salmonella bacteraemia.
Findings suggest climate–infection interplay with implications for AMR trends.
journals.sagepub.com/doi/full/10....
Rising temperature, humidity, and monsoon rainfall were linked to increased Salmonella bacteraemia.
Findings suggest climate–infection interplay with implications for AMR trends.
journals.sagepub.com/doi/full/10....
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
October 28, 2025 at 1:10 PM
📈 Retrospective time-series study (2014–2019, Mysuru, India):
Rising temperature, humidity, and monsoon rainfall were linked to increased Salmonella bacteraemia.
Findings suggest climate–infection interplay with implications for AMR trends.
journals.sagepub.com/doi/full/10....
Rising temperature, humidity, and monsoon rainfall were linked to increased Salmonella bacteraemia.
Findings suggest climate–infection interplay with implications for AMR trends.
journals.sagepub.com/doi/full/10....
Reposted by Andres Henao, MD PhD FIDSA
🚨study from Bolivia: A novel PCR platform—Orange G3 TBC—shows comparable accuracy to GeneXpert Ultra for TB diagnosis (sensitivity = 90%, specificity = 97%). Its biosafe, low-resource–friendly design could expand TB testing access in endemic settings.
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
Diagnostic accuracy of the novel and biosafe molecular assay Orange G3 TBC compared to GeneXpert for tuberculosis diagnosis in resource-limited settings - Juan Carlos Garberi, Gabriel Estryk, Richard ...
Background: Tuberculosis (TB) remains a global public health priority, with 10.5 million new cases and 1.5 million deaths reported in 2023. Current diagnostic m...
journals.sagepub.com
October 22, 2025 at 12:47 PM
🚨study from Bolivia: A novel PCR platform—Orange G3 TBC—shows comparable accuracy to GeneXpert Ultra for TB diagnosis (sensitivity = 90%, specificity = 97%). Its biosafe, low-resource–friendly design could expand TB testing access in endemic settings.
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
Reposted by Andres Henao, MD PhD FIDSA
Excellent comprehensive review on #Syphilis just published in #JAMA. An old disease and a powerful mimic. Interpreting syphilis serologies and how to treat is probably one of the consult questions ID physicians get the most.
#IDSky #MedSky
jamanetwork.com/journals/jam...
#IDSky #MedSky
jamanetwork.com/journals/jam...
Syphilis: A Review
This review summarizes the epidemiology, clinical manifestations, staging, and diagnosis of syphilis.
jamanetwork.com
October 16, 2025 at 7:19 PM
Excellent comprehensive review on #Syphilis just published in #JAMA. An old disease and a powerful mimic. Interpreting syphilis serologies and how to treat is probably one of the consult questions ID physicians get the most.
#IDSky #MedSky
jamanetwork.com/journals/jam...
#IDSky #MedSky
jamanetwork.com/journals/jam...
Reposted by Andres Henao, MD PhD FIDSA
In a survey of 128 HIV care workers, negative attitudes toward people who use drugs were strongly linked to lower acceptance of harm reduction practices. Acceptance varied by site, race, and experience—pointing to structural and training gaps.
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
Attitudes of HIV healthcare Provider Attitudes Towards PWH who use Drugs and acceptance of harm reduction strategies: a cross-sectional study - Rabab F. M. Ahmed, Robert W. S. Coulter, M. Reuel Friedm...
Background: Negative attitudes toward people who use drugs (PWUD) can hinder their engagement in healthcare and contribute to poor clinical outcomes. While harm...
journals.sagepub.com
October 15, 2025 at 1:02 PM
In a survey of 128 HIV care workers, negative attitudes toward people who use drugs were strongly linked to lower acceptance of harm reduction practices. Acceptance varied by site, race, and experience—pointing to structural and training gaps.
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
Reposted by Andres Henao, MD PhD FIDSA
Systematic review/meta-analysis (2013–2024, n=23,319): In febrile neutropenia after chemotherapy, bloodstream infections were 59% Gram-negative, 39.7% Gram-positive, and 2.5% fungal.
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
October 10, 2025 at 12:41 PM
Systematic review/meta-analysis (2013–2024, n=23,319): In febrile neutropenia after chemotherapy, bloodstream infections were 59% Gram-negative, 39.7% Gram-positive, and 2.5% fungal.
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
Reposted by Andres Henao, MD PhD FIDSA
Six of the nine Nobel Prize winners this year work in the U.S.
Three of the six were born outside the U.S., which is the pattern most years. No country has benefited more from welcoming immigrants from around the world.
www.nobelprize.org
Three of the six were born outside the U.S., which is the pattern most years. No country has benefited more from welcoming immigrants from around the world.
www.nobelprize.org
The official website of the Nobel Prize - NobelPrize.org
The Nobel Prize rewards science, humanism and peace efforts. This is one of the central concepts in the will of Alfred Nobel, and it also permeates the outreach activities that have been developed for...
www.nobelprize.org
October 8, 2025 at 12:37 PM
Six of the nine Nobel Prize winners this year work in the U.S.
Three of the six were born outside the U.S., which is the pattern most years. No country has benefited more from welcoming immigrants from around the world.
www.nobelprize.org
Three of the six were born outside the U.S., which is the pattern most years. No country has benefited more from welcoming immigrants from around the world.
www.nobelprize.org
Reposted by Andres Henao, MD PhD FIDSA
Bureaucratic delays and chronic underfunding are hallmarks of doing science in Global South countries. And we hear about such challenges often. New report documenting how scientists in countries like Kenya and India navigate such challenges. Lots of tips here and a vision for a collaborative future
October 8, 2025 at 3:06 AM
Bureaucratic delays and chronic underfunding are hallmarks of doing science in Global South countries. And we hear about such challenges often. New report documenting how scientists in countries like Kenya and India navigate such challenges. Lots of tips here and a vision for a collaborative future
Reposted by Andres Henao, MD PhD FIDSA
The Clade IIb #mpox 🌍 outbreak exposed major gaps in evidence for antivirals 💊, vaccine equity 💉, and surveillance. This review maps the path toward targeted, evidence-based treatments and prevention✨
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
October 7, 2025 at 1:13 PM
The Clade IIb #mpox 🌍 outbreak exposed major gaps in evidence for antivirals 💊, vaccine equity 💉, and surveillance. This review maps the path toward targeted, evidence-based treatments and prevention✨
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
Reposted by Andres Henao, MD PhD FIDSA
September 28, 2025 at 12:11 AM
Reposted by Andres Henao, MD PhD FIDSA
If you can make it here, you can make it anywhere, it's up to you...Chikungunya in my home town. www.nytimes.com/2025/09/25/n...
Mosquito-Borne Illness Rarely Seen in U.S. Is Suspected on Long Island
www.nytimes.com
September 26, 2025 at 10:24 AM
If you can make it here, you can make it anywhere, it's up to you...Chikungunya in my home town. www.nytimes.com/2025/09/25/n...
Reposted by Andres Henao, MD PhD FIDSA
Acquired amphotericin B resistance attributed to a mutated ERG3 in Candidozyma auris | Antimicrobial Agents and Chemotherapy journals.asm.org/doi/full/10....
Acquired amphotericin B resistance attributed to a mutated ERG3 in Candidozyma auris | Antimicrobial Agents and Chemotherapy
In 2019, the Centers for Disease Control and Prevention (CDC) designated Candidozyma auris (previously known as Candida auris) as an urgent antimicrobial threat, making it the first fungal pathogen to...
journals.asm.org
September 25, 2025 at 3:41 PM
Acquired amphotericin B resistance attributed to a mutated ERG3 in Candidozyma auris | Antimicrobial Agents and Chemotherapy journals.asm.org/doi/full/10....
Reposted by Andres Henao, MD PhD FIDSA
Hospital clinician training transformed care for PWUD w/ severe infections. Post-training: 95% applied harm reduction (vs 55%), 69% discussed safer use (vs 38%).
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
A descriptive survey evaluating the implementation and outcomes of a training session highlighting concepts in antimicrobial management and harm reduction for hospital-based clinicians treating person...
Background: People who use drugs (PWUD) are at increased risk for severe infections and face many barriers when completing conventional, typically parenteral an...
journals.sagepub.com
September 23, 2025 at 1:42 PM
Hospital clinician training transformed care for PWUD w/ severe infections. Post-training: 95% applied harm reduction (vs 55%), 69% discussed safer use (vs 38%).
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
Reposted by Andres Henao, MD PhD FIDSA
The @washingtonpost.com story on Tylenol & autism leaves out a MAJOR 2.5M sibling-controlled study of children in Denmark, which "found no evidence that acetaminophen use during pregnancy was associated with children’s risk of autism, ADHD or intellectual disability." jamanetwork.com/journals/jam...
Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability
This nationwide cohort study with sibling control analysis examines the association of acetaminophen use during pregnancy with children’s risk of autism, ADHD, and intellectual disability.
jamanetwork.com
September 22, 2025 at 9:43 AM
The @washingtonpost.com story on Tylenol & autism leaves out a MAJOR 2.5M sibling-controlled study of children in Denmark, which "found no evidence that acetaminophen use during pregnancy was associated with children’s risk of autism, ADHD or intellectual disability." jamanetwork.com/journals/jam...
Reposted by Andres Henao, MD PhD FIDSA
We are excited to celebrate the success of 24 Hours to Save AIDS Research by announcing that the entire program is now available on YouTube. 1/
www.youtube.com/@HIVAIDSarou...
www.youtube.com/@HIVAIDSarou...
24hrs_to_save_AIDS_research
Over the past four decades, HIV research has saved tens of millions of lives through discoveries in HIV treatment and prevention, with the US federal government playing a foundational role in that suc...
www.youtube.com
September 21, 2025 at 2:20 PM
We are excited to celebrate the success of 24 Hours to Save AIDS Research by announcing that the entire program is now available on YouTube. 1/
www.youtube.com/@HIVAIDSarou...
www.youtube.com/@HIVAIDSarou...
Reposted by Andres Henao, MD PhD FIDSA
Dismantling childhood vaccination programs is medical malpractice
Just stating the obvious
Just stating the obvious
September 19, 2025 at 2:18 PM
Dismantling childhood vaccination programs is medical malpractice
Just stating the obvious
Just stating the obvious
Reposted by Andres Henao, MD PhD FIDSA
🌍 TIMM 2025: Join the One Health Lunch Meeting on Sept 21, 2025 (12:30–2:00 PM, Room 3A)!
Topic: AMR – Fungal One Health Coalition for global strategies to combat AntiMycotic Resistance.
Hosts: Michaela Lackner & Paul Verweij.
🍴 Everyone welcome—bring your colleagues!
Topic: AMR – Fungal One Health Coalition for global strategies to combat AntiMycotic Resistance.
Hosts: Michaela Lackner & Paul Verweij.
🍴 Everyone welcome—bring your colleagues!
September 19, 2025 at 11:48 AM
🌍 TIMM 2025: Join the One Health Lunch Meeting on Sept 21, 2025 (12:30–2:00 PM, Room 3A)!
Topic: AMR – Fungal One Health Coalition for global strategies to combat AntiMycotic Resistance.
Hosts: Michaela Lackner & Paul Verweij.
🍴 Everyone welcome—bring your colleagues!
Topic: AMR – Fungal One Health Coalition for global strategies to combat AntiMycotic Resistance.
Hosts: Michaela Lackner & Paul Verweij.
🍴 Everyone welcome—bring your colleagues!
Reposted by Andres Henao, MD PhD FIDSA
Here are the first vaccine recommendations issued by the West Coast Health Alliance, which includes California, Washington, Oregon, and Hawaii:
September 17, 2025 at 7:12 PM
Here are the first vaccine recommendations issued by the West Coast Health Alliance, which includes California, Washington, Oregon, and Hawaii:
Reposted by Andres Henao, MD PhD FIDSA
🦠 Ebola Outbreak — Kasai, DRC (Sitrep 15 Sept 2025)
- 54 cases, 27 deaths, incl. 4 health workers
- Epicenter: Bulape & Mweka zones
- Vaccination with Ervebo underway for health workers & contacts
- WHO risk: High (national), Moderate (regional), Low (global)
iris.who.int/bitstream/ha...
- 54 cases, 27 deaths, incl. 4 health workers
- Epicenter: Bulape & Mweka zones
- Vaccination with Ervebo underway for health workers & contacts
- WHO risk: High (national), Moderate (regional), Low (global)
iris.who.int/bitstream/ha...
September 17, 2025 at 2:18 AM
🦠 Ebola Outbreak — Kasai, DRC (Sitrep 15 Sept 2025)
- 54 cases, 27 deaths, incl. 4 health workers
- Epicenter: Bulape & Mweka zones
- Vaccination with Ervebo underway for health workers & contacts
- WHO risk: High (national), Moderate (regional), Low (global)
iris.who.int/bitstream/ha...
- 54 cases, 27 deaths, incl. 4 health workers
- Epicenter: Bulape & Mweka zones
- Vaccination with Ervebo underway for health workers & contacts
- WHO risk: High (national), Moderate (regional), Low (global)
iris.who.int/bitstream/ha...